Price range: £155.25 through £456.38
Tesamorelin is a Tesamorelin peptide designed as a stabilized analogue of Growth Hormone Releasing Hormone (GHRH). Researchers use this peptide to study growth hormone secretion, hypothalamic–pituitary communication, and metabolic signaling models in controlled laboratory environments. Because Tesamorelin includes a trans-3-hexenoic acid modification, it offers increased stability compared with native GHRH sequences. This enhancement enables clearer timing and stronger receptor engagement during experimental work.
Scientists value the Tesamorelin peptide for its ability to stimulate pituitary GH release in vitro or ex vivo with predictable kinetic patterns. It supports investigations into intracellular signaling cascades, GH-pulse dynamics, and downstream pathways linked to metabolism and body composition. Furthermore, Tesamorelin allows researchers to evaluate differences between modified GHRH analogues and natural hormone fragments such as Sermorelin.
Laboratory teams often buy the Tesamorelin peptide for:
Studying GH secretion responses under isolated conditions
Analysing receptor-binding behavior and activation timing
Mapping metabolic pathways linked to GHRH stimulation
Comparing stability and potency among GHRH peptide analogues
The Tesamorelin peptide helps support reproducible experiments focused on precision endocrine modeling. Its performance characteristics enable accurate dose-response tracking, reliable signaling analysis, and consistent replication across assays and research programs.
This Tesamorelin peptide is supplied as a high-purity laboratory reagent intended only for qualified scientific professionals. It is not approved for clinical, therapeutic, diagnostic, or veterinary use. All handling must follow appropriate institutional safety procedures and regulatory guidelines.
For research use only. Not for human consumption.
Discount Applied Successfully!
Your savings have been added to the cart.
